Healthcare Triangle, Inc. — Form 8-K Summary
Business context and reporting period
Healthcare Triangle, Inc. filed a Form 8-K on June 29, 2023, reporting an event occurring on June 23, 2023. The filing concerns a default notice under the company’s purchasing agreement with Seacoast Business Funding, a division of Seacoast National Bank.
Financial position and material obligation
- As of June 28, 2023, the company reported an outstanding payment balance of $2,409,437 under the Seacoast Purchasing Agreement dated May 2, 2022.
- Following the alleged default, the fee payable to Seacoast increased from the applicable prime rate to 18%.
- On May 5, 2023, the company received a $1.5 million advance under a separate Business Loan and Security Agreement with Agile Lending, LLC and Agile Capital Funding, LLC as collateral agent.
- The filing does not provide revenue, profit, cash-flow, margin, total-debt, or broader liquidity metrics.
Material change versus the prior comparable period
The filing reports a new default notice and an increased financing fee under the Seacoast agreement. The alleged default arose because the company obtained the $1.5 million Agile financing without obtaining Seacoast’s prior written consent, as required by Section 6(h) of the Purchasing Agreement.
Outlook, risks, contingencies, and unusual items
- As of the filing date, Seacoast had not accelerated the company’s obligations, foreclosed on collateral, or otherwise enforced its rights under the Purchasing Agreement.
- The company is attempting to resolve the matter and may defend any enforcement action.
- Management stated that it cannot guarantee a timely or favorable resolution, or any resolution at all.
- If the alleged defaults are not resolved, the company expects a material adverse effect on liquidity, financial condition, and results of operations, potentially including bankruptcy or insolvency.
Key facts investors should verify
- Whether Seacoast has accelerated the $2.41 million obligation or taken enforcement action after the filing.
- The current interest or fee rate and total amount accruing under the Seacoast agreement.
- The status, terms, collateral, and repayment requirements of the $1.5 million Agile financing.
- Whether the company has obtained a waiver, amendment, or other negotiated resolution from Seacoast.
- The effect of these obligations and any enforcement activity on the company’s liquidity, solvency, and future operations.